V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006058 | 10003888 | 1.62 | 80 | null | 2017-10-28 | 2017-11-07 | Rituximab (Maintenance) | 02 | N | 10344281 | RITUXIMAB |
| 10006059 | 10003888 | 1.48 | 52.7 | Palliative (P) | 2016-06-02 | 2017-05-07 | Paclitaxel 7 day | N | N | 10344281 | PACLITAXEL |
| 10006060 | 10003888 | 1.89 | 78 | Palliative (P) | 2018-02-08 | 2018-03-18 | Capecitabine + Oxaliplatin 21day | 02 | N | 10344281 | CAPECITABINE + OXALIPLATIN |
| 10006061 | 10003889 | 0 | 85.7 | Curative (C) | 2019-03-25 | 2019-03-28 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10344960 | RITUXIMAB |
| 10006062 | 10003890 | 1.58 | 0 | Palliative (P) | 2018-08-09 | 2018-08-10 | Trastuzumab Subcutaneous | N | N | 10345302 | TRASTUZUMAB |
| 10006063 | 10003890 | 1.92 | 67.2 | Adjuvant (A) | 2016-11-11 | 2016-11-15 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10345302 | PACLITAXEL |
| 10006064 | 10003890 | 0 | 0 | Palliative (P) | 2018-07-25 | 2018-07-31 | CAPECITABINE + OXALIPLATIN | N | Y | 10345302 | CAPECITABINE + OXALIPLATIN |
| 10006065 | 10003890 | 1.63 | 75.8 | Palliative (P) | 2017-08-11 | 2017-08-17 | CHOP R | 02 | N | 10345302 | CHOP R |
| 10006066 | 10003892 | 1.63 | 62.9 | Adjuvant (A) | 2017-08-25 | 2017-09-17 | Paclitaxel 7 day | N | N | 10345907 | PACLITAXEL |
| 10006067 | 10003893 | 1.48 | 65.3 | null | 2016-08-25 | 2016-08-25 | Rituximab (Maintenance) | N | N | 10345907 | RITUXIMAB |
| 10006068 | 10003893 | 1.73 | 80 | Palliative (P) | 2019-01-07 | 2019-05-11 | Irinotecan + Modified De Gramont | N | N | 10345907 | IRINOTECAN + MDG |
| 10006069 | 10007081 | 1.82 | 67.8 | Palliative (P) | 2003-06-01 | 2017-07-28 | CHOP R - 21 days | 02 | N | 10346241 | CHOP R |
| 10006070 | 10003898 | 1.58 | 49.9 | Adjuvant (A) | 2014-02-05 | 2014-02-05 | Rituximab | 2 | N | 10346330 | RITUXIMAB |
| 10006071 | 10003899 | 1.83 | 86 | Adjuvant (A) | 2016-03-19 | 2016-03-19 | CAPECITABINE + OXALIPLATIN | 02 | N | 10346871 | CAPECITABINE + OXALIPLATIN |
| 10006072 | 10003900 | 1.68 | 80 | null | 2017-04-23 | 2017-05-07 | FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | 02 | N | 10347518 | OXALIPLATIN + MDG |
| 10006073 | 10003900 | 1.6 | 67.4 | Curative (C) | 2016-07-17 | 2016-07-18 | TRASTUZUMAB | N | N | 10347518 | TRASTUZUMAB |
| 10006074 | 10003901 | 1.68 | 70.9 | null | 2018-11-24 | 2018-12-08 | PEMBROLIZUMAB | 02 | N | 10347859 | PEMBROLIZUMAB |
| 10006075 | 10003902 | 1.57 | 82 | Disease modification (D) | 2018-02-26 | 2018-11-01 | Trastuzumab Subcutaneous | 2 | N | 10348000 | TRASTUZUMAB |
| 10006076 | 10003903 | 1.65 | 91.9 | Unknown (U) | 2016-12-13 | 2016-12-27 | CHOP R | 2 | N | 10348000 | CHOP R |
| 10006077 | 10008383 | 1.65 | 69.6 | Curative (C) | 2014-03-10 | 2014-03-22 | Trastuzumab Subcutaneous | 2 | N | 10348009 | TRASTUZUMAB |
| 10006078 | 10008383 | null | 71 | Curative (C) | 2014-09-06 | 2014-09-13 | Oxaliplatin + Modified de Gramont | N | null | 10348009 | OXALIPLATIN + MDG |
| 10006079 | 10009243 | 1.59 | 83.5 | Disease modification (D) | 2017-10-15 | 2017-10-15 | FLUOROURACIL + OXALIPLATIN | 02 | null | 10348760 | OXALIPLATIN + MDG |
| 10006080 | 10003904 | 1.7 | 55 | Neo-adjuvant (N) | 2018-10-28 | 2018-10-28 | Irinotecan + Modified De Gramont | N | N | 10348950 | IRINOTECAN + MDG |
| 10006081 | 10003904 | 1.86 | 75 | Disease modification (D) | 2017-05-15 | 2017-06-13 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 10348950 | PACLITAXEL |
| 10006082 | 10003904 | 1.71 | 66.6 | null | 2016-08-17 | 2016-08-25 | Rituximab | N | N | 10348950 | RITUXIMAB |
| 10006083 | 10003905 | 0 | 70.3 | Adjuvant (A) | 2018-12-10 | 2018-12-14 | FLUOROURACIL + IRINOTECAN | 2 | N | 10349713 | IRINOTECAN + MDG |
| 10006084 | 10007086 | 1.73 | 98.8 | Adjuvant (A) | 2015-04-07 | 2015-04-18 | TRASTUZUMAB | 02 | N | 10349915 | TRASTUZUMAB |
| 10006085 | 10007086 | null | 109 | Palliative (P) | 2016-12-30 | 2016-12-31 | Irinotecan + Modified De Gramont | N | N | 10349915 | IRINOTECAN + MDG |
| 10006086 | 10003906 | 1.68 | 70 | Adjuvant (A) | 2019-01-30 | 2019-02-03 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 10350032 | PACLITAXEL |
| 10006087 | 10003907 | 1.56 | 99 | Disease modification (D) | 2018-08-08 | 2018-08-08 | Oxaliplatin + Modified de Gramont | N | N | 10350301 | OXALIPLATIN + MDG |
| 10006088 | 10003908 | 1.7 | 74 | Disease modification (D) | 2015-07-12 | 2015-08-10 | Trastuzumab Subcutaneous | N | N | 10350333 | TRASTUZUMAB |
| 10006089 | 10003909 | 1.67 | 72.7 | null | 2018-01-12 | 2018-02-12 | Docetaxel 100mg/m2 (21 day) | 2 | null | 10350371 | DOCETAXEL |
| 10006090 | 10003910 | 1.46 | 68 | Adjuvant (A) | 2015-11-20 | 2016-05-21 | Rituximab | N | N | 10350855 | RITUXIMAB |
| 10006091 | 10003912 | 1.53 | 50.1 | Disease modification (D) | 2015-07-27 | 2015-08-03 | PACLITAXEL | 02 | N | 10351112 | PACLITAXEL |
| 10006092 | 10003912 | 1.77 | 80.3 | Palliative (P) | 2016-12-26 | 2016-12-26 | CAPECITABINE + OXALIPLATIN | N | N | 10351112 | CAPECITABINE + OXALIPLATIN |
| 10006093 | 10003913 | 1.69 | 83 | Not known (9) | null | 2018-09-15 | Irinotecan + Modified De Gramont | N | N | 10351548 | IRINOTECAN + MDG |
| 10006094 | 10003914 | 0 | 102 | Palliative (P) | 2014-05-03 | 2015-03-05 | Docetaxel | 02 | N | 10351591 | DOCETAXEL |
| 10006095 | 10003915 | 1.68 | 80.8 | Curative (C) | 2018-10-01 | 2018-10-08 | Trastuzumab Subcutaneous | N | N | 10351696 | TRASTUZUMAB |
| 10006096 | 10003915 | 1.7 | null | Disease modification (D) | 2018-02-21 | 2018-02-27 | Oxaliplatin + Modified de Gramont | 02 | N | 10351696 | OXALIPLATIN + MDG |
| 10006097 | 10003916 | 1.71 | 67.8 | Curative (C) | 2018-03-18 | 2018-08-01 | CHOP R - 21 days | N | N | 10351865 | CHOP R |
| 10006098 | 10003916 | 1.53 | 61.6 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-12 | Docetaxel | N | N | 10351865 | DOCETAXEL |
| 10006099 | 10003917 | 1.73 | 64.7 | Adjuvant (A) | 2016-10-03 | 2016-10-13 | Rituximab | N | N | 10352469 | RITUXIMAB |
| 10006100 | 10003917 | 1.66 | 57.4 | null | null | 2018-07-29 | Docetaxel | null | N | 10352469 | DOCETAXEL |
| 10006101 | 10008389 | 1.65 | 77 | Palliative (P) | 2019-03-10 | 2019-04-10 | Rituximab (Maintenance) | N | N | 10353480 | RITUXIMAB |
| 10006102 | 10003918 | null | 73.7 | Palliative (P) | 2016-01-31 | 2016-02-14 | PACLITAXEL | 02 | N | 10353654 | PACLITAXEL |
| 10006103 | 10007091 | 1.63 | 72 | Palliative (P) | 2018-01-11 | 2018-02-02 | PACLITAXEL | null | 2 | 10353888 | PACLITAXEL |
| 10006104 | 10003919 | 1.66 | 94 | Adjuvant (A) | 2015-10-26 | 2016-01-03 | CAPECITABINE + OXALIPLATIN | 02 | N | 10354011 | CAPECITABINE + OXALIPLATIN |
| 10006105 | 10003921 | 1.71 | 63.1 | Curative (C) | 2018-08-06 | 2018-09-03 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10354165 | RITUXIMAB |
| 10006106 | 10003922 | 1.78 | 52.5 | Palliative (P) | 2018-02-24 | 2018-02-26 | Oxaliplatin + Modified de Gramont | N | N | 10354177 | OXALIPLATIN + MDG |
| 10006107 | 10003923 | 1.78 | 55.7 | Curative (C) | 2018-09-29 | 2018-12-06 | Rituximab | 2 | N | 10354202 | RITUXIMAB |